Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katrine Melvold"'
Autor:
Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord, Sigrid S. Skånland
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract The microenvironment of chronic lymphocytic leukemia (CLL) cells in lymph nodes, spleen, and bone marrow provides survival, proliferation, and drug resistance signals. Therapies need to be effective in these compartments, and pre-clinical mo
Externí odkaz:
https://doaj.org/article/c9d49e1d86744257bcc85e229f404a21
Autor:
Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Sigrid S. Skånland
Publikováno v:
Molecular Oncology, Vol 16, Iss 5, Pp 1153-1170 (2022)
Most patients with chronic lymphocytic leukemia (CLL) initially respond to targeted therapies, but eventually relapse and develop resistance. Novel treatment strategies are therefore needed to improve patient outcomes. Here, we performed direct drug
Externí odkaz:
https://doaj.org/article/67352beffad14b0ba011733748ab3689
Autor:
null Katrine Melvold, null Mariaserena Giliberto, null Linda Karlsen, null Pilar Ayuda‐Durán, null Robert Hanes, null Toril Holien, null Jorrit Enserink, null Jennifer R. Brown, null Geir E. Tjønnfjord, null Kjetil Taskén, null Sigrid S. Skånland
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e0b2c80854590d5c5ef488afb15ccc0
https://doi.org/10.1002/1878-0261.13153/v2/response1
https://doi.org/10.1002/1878-0261.13153/v2/response1
Autor:
Katrine Melvold, Mariaserena Giliberto, Jorrit M. Enserink, Linda Karlsen, Sigrid S. Skånland, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Robert Hanes, Pilar Ayuda-Durán, Toril Holien
Publikováno v:
Molecular Oncology
Most patients with chronic lymphocytic leukemia (CLL) initially respond to targeted therapies, but eventually relapse and develop resistance. Novel treatment strategies are therefore needed to improve patient outcomes. Here, we performed direct drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4643c552e9397d1872ff5349286a680
http://hdl.handle.net/10852/91053
http://hdl.handle.net/10852/91053
Autor:
Hermansen, Johanne U., Yin, Yanping, Urban, Aleksandra, Myklebust, Camilla V., Karlsen, Linda, Melvold, Katrine, Tveita, Anders A., Taskén, Kjetil, Munthe, Ludvig A., Tjønnfjord, Geir E., Skånland, Sigrid S.
Publikováno v:
Cell Death Discovery; 4/13/2023, Vol. 9 Issue 1, p1-10, 10p
Autor:
Melvold, Katrine, Giliberto, Mariaserena, Karlsen, Linda, Ayuda‐Durán, Pilar, Hanes, Robert, Holien, Toril, Enserink, Jorrit, Brown, Jennifer R., Tjønnfjord, Geir E., Taskén, Kjetil, Skånland, Sigrid S.
Publikováno v:
Molecular Oncology; Mar2022, Vol. 16 Issue 5, p1153-1170, 18p
Publikováno v:
Hematology Week; 5/5/2023, p1890-1890, 1p